Vineis P, Airoldi L, Veglia F, Olgiati L, Pastorelli R, Autrup H, Dunning A, Garte S, Gormally E, Hainaut P, Malaveille C, Matullo G, Peluso M, Overvad K, Tjonneland A, Clavel-Chapelon F, Boeing H, Krogh V, Palli D, Panico S, Tumino R, Bueno-De-Mesquita B, Peeters P, Berglund G, Hallmans G, Saracci R, Riboli E
Imperial College, London W2 1PG.
BMJ. 2005 Feb 5;330(7486):277. doi: 10.1136/bmj.38327.648472.82. Epub 2005 Jan 28.
To investigate the association between environmental tobacco smoke, plasma cotinine concentration, and respiratory cancer or death.
Nested case-control study within the European prospective investigation into cancer and nutrition (EPIC).
303,020 people from the EPIC cohort (total 500,000) who had never smoked or who had stopped smoking for at least 10 years, 123,479 of whom provided information on exposure to environmental tobacco smoke. Cases were people who developed respiratory cancers or died from respiratory conditions. Controls were matched for sex, age (plus or minus 5 years), smoking status, country of recruitment, and time elapsed since recruitment.
Newly diagnosed cancer of lung, pharynx, and larynx; deaths from chronic obstructive pulmonary disease or emphysema. Plasma cotinine concentration was measured in 1574 people.
Over seven years of follow up, 97 people had newly diagnosed lung cancer, 20 had upper respiratory cancers (pharynx, larynx), and 14 died from chronic obstructive pulmonary disease or emphysema. In the whole cohort exposure to environmental tobacco smoke was associated with increased risks (hazard ratio 1.30, 95% confidence interval 0.87 to 1.95, for all respiratory diseases; 1.34, 0.85 to 2.13, for lung cancer alone). Higher results were found in the nested case-control study (odds ratio 1.70, 1.02 to 2.82, for respiratory diseases; 1.76, 0.96 to 3.23, for lung cancer alone). Odds ratios were consistently higher in former smokers than in those who had never smoked; the association was limited to exposure related to work. Cotinine concentration was clearly associated with self reported exposure (3.30, 2.07 to 5.23, for detectable/non-detectable cotinine), but it was not associated with the risk of respiratory diseases or lung cancer. Frequent exposure to environmental tobacco smoke during childhood was associated with lung cancer in adulthood (hazard ratio 3.63, 1.19 to 11.11, for daily exposure for many hours).
This large prospective study, in which the smoking status was supported by cotinine measurements, confirms that environmental tobacco smoke is a risk factor for lung cancer and other respiratory diseases, particularly in ex-smokers.
研究环境烟草烟雾、血浆可替宁浓度与呼吸道癌症或死亡之间的关联。
在欧洲癌症与营养前瞻性调查(EPIC)中进行巢式病例对照研究。
EPIC队列(共500,000人)中303,020名从不吸烟或已戒烟至少10年的人,其中123,479人提供了环境烟草烟雾暴露信息。病例为患呼吸道癌症或死于呼吸道疾病的人。对照按性别、年龄(±5岁)、吸烟状况、招募国家和招募后经过的时间进行匹配。
新诊断的肺癌、咽癌和喉癌;慢性阻塞性肺疾病或肺气肿导致的死亡。对1574人测量了血浆可替宁浓度。
在七年的随访中,97人新诊断为肺癌,20人患上部呼吸道癌症(咽、喉),14人死于慢性阻塞性肺疾病或肺气肿。在整个队列中,环境烟草烟雾暴露与风险增加相关(所有呼吸道疾病的风险比为1.30,95%置信区间为0.87至1.95;仅肺癌的风险比为1.34,0.85至2.13)。在巢式病例对照研究中发现了更高的结果(呼吸道疾病的比值比为1.70,1.02至2.82;仅肺癌的比值比为1.76,0.96至3.23)。前吸烟者的比值比始终高于从不吸烟者;这种关联仅限于与工作相关的暴露。可替宁浓度与自我报告的暴露明显相关(可检测/不可检测可替宁的比值比为3.30,2.07至5.23),但与呼吸道疾病或肺癌的风险无关。儿童时期频繁暴露于环境烟草烟雾与成年后患肺癌相关(许多小时每日暴露的风险比为3.63,1.19至11.11)。
这项大型前瞻性研究通过可替宁测量来支持吸烟状况,证实环境烟草烟雾是肺癌和其他呼吸道疾病的危险因素,尤其是在曾经吸烟者中。